Adenovirus News and Research

RSS
Adenoviruses most commonly cause respiratory illness; however, depending on the infecting serotype, they may also cause various other illnesses, such as gastroenteritis, conjunctivitis, cystitis, and rash illness. Symptoms of respiratory illness caused by adenovirus infection range from the common cold syndrome to pneumonia, croup, and bronchitis. Patients with compromised immune systems are especially susceptible to severe complications of adenovirus infection. Acute respiratory disease (ARD), first recognized among military recruits during World War II, can be caused by adenovirus infections during conditions of crowding and stress.
Positive results from Chimerix CMX001 study for CMV in hematopoietic stem cell transplant recipients

Positive results from Chimerix CMX001 study for CMV in hematopoietic stem cell transplant recipients

Mass. Eye and Ear cornea specialist wins RPB Senior Scientific Investigator Award

Mass. Eye and Ear cornea specialist wins RPB Senior Scientific Investigator Award

Critical considerations for adenovirus-based HIV vaccine trials

Critical considerations for adenovirus-based HIV vaccine trials

New gene editing technique can heal sickle cell patients with their own cells

New gene editing technique can heal sickle cell patients with their own cells

Gene-therapy trial to restore hearing in deaf mice

Gene-therapy trial to restore hearing in deaf mice

Thyroid researcher to receive ATA's John B. Stanbury Pathophysiology Medal

Thyroid researcher to receive ATA's John B. Stanbury Pathophysiology Medal

New insights into how adenovirus triggers an immune response

New insights into how adenovirus triggers an immune response

Virus DNA uncoated with aid of host cell

Virus DNA uncoated with aid of host cell

MRI-based technique allows researchers to follow neural stem cells in vivo

MRI-based technique allows researchers to follow neural stem cells in vivo

BARDA awards Vaxin $21.7M contract to accelerate development of novel anthrax vaccine

BARDA awards Vaxin $21.7M contract to accelerate development of novel anthrax vaccine

Inovio achieves best-in-class immune responses in PENNVAX-B HIV vaccine Phase I study

Inovio achieves best-in-class immune responses in PENNVAX-B HIV vaccine Phase I study

Novel studies explore new targets to prevent spread of breast cancer

Novel studies explore new targets to prevent spread of breast cancer

Insect virus holds key to safer stem cell therapy: Singapore scientists

Insect virus holds key to safer stem cell therapy: Singapore scientists

Cell biologists identify infection mechanism of adenoviruses

Cell biologists identify infection mechanism of adenoviruses

Localized one-time gene therapy might effectively protect against atherosclerosis

Localized one-time gene therapy might effectively protect against atherosclerosis

Chimerix initiates CMX001 Phase 2 study for prevention of adenovirus disease following HSCT

Chimerix initiates CMX001 Phase 2 study for prevention of adenovirus disease following HSCT

UTHealth receives $1M FEMA grant to examine link between Ad-36 infection, obesity

UTHealth receives $1M FEMA grant to examine link between Ad-36 infection, obesity

Crucell, GSK and PATH MVI partner to develop second-generation vaccine against malaria

Crucell, GSK and PATH MVI partner to develop second-generation vaccine against malaria

PATH malaria vaccine initiative to collaborate with GSK and Crucell in development of 2nd-generation malaria vaccine

PATH malaria vaccine initiative to collaborate with GSK and Crucell in development of 2nd-generation malaria vaccine

Novel ultrasound-targeted microbubble-destruction technology advances cure for prostate cancer

Novel ultrasound-targeted microbubble-destruction technology advances cure for prostate cancer